The top-down approach in the system adds to the problem. Giving a toolbox of policy interventions with requisite autonomy to the local government is a way to go forward. Adequate training of our existing healthcare workforce in nutrition is pertinent and will lead to better health outcomes. Unification of all malnutrition schemes into a single Ministry of Nutrition will help in consolidation of efforts and resources. The ministry should be made responsible for all nutrition-related interventions ranging from Anganwadi services scheme, mid-day meals to ration distribution. The establishment of a nutrition cadre at the village level to reduce the burden of nutrition interventions on overworked Anganwadi workers is an essential step.
‘Is India’s Economic Growth Hiding its Hunger Crisis?’, News18
2 notes
·
View notes
BJP Business Cell Distributes 650 Ayushman Cards in Jamshedpur
State Convener Neeraj Singh criticizes Jharkhand government at Kadma event
BJP’s Business Cell handed out Ayushman cards to 650 beneficiaries in Jamshedpur West Assembly constituency.
JAMSHEDPUR – The BJP Business Cell distributed 650 Ayushman cards at Shastri Nagar Tarun Sangh premises in Kadma Mandal, part of the Jamshedpur West Assembly constituency.
Neeraj Singh, State Convener of the BJP…
0 notes
Healthcare Distribution Market Poised to Witness Substantial Growth due to Burgeoning Pharmaceutical Sales
Healthcare distribution involves transportation and delivery of pharmaceuticals, medical devices and vaccines to healthcare facilities such as hospitals, retail and mail pharmacies. Growing demand for medicines, medical equipment and vaccines globally has prompted manufacturers to outsource distribution activities to specialist healthcare distributors having nationwide warehousing and delivery networks. This has streamlined pharmaceutical supply chains and ensured uninterrupted availability of products at point of care. The global market is driven by rising healthcare expenditure, aging population suffering from chronic diseases and growth in generic drug sales.
The global healthcare distribution market is estimated to be valued at US$ 1,633.1 Bn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period of 2024 to 2031.
Key Takeaways
Key players operating in the healthcare distribution market are AmerisourceBergen Corporation, McKesson Corporation, Medline Industries, Cardinal Health, Inc., PHOENIX Group, Shanghai Pharmaceutical Group Co., Ltd., Henry Schein Inc., Owens & Minor, Inc., Medline Industries, Rochester Drug Cooperative, Inc., FFF Enterprises, Inc., Dakota Drug, Inc., Mutual Drug Company, Shields Health Solutions, Value Drug Company, Consorta, Inc. Key players are focusing on mergers and acquisitions to expand product portfolio and geographical presence. For instance, in 2023, AmerisourceBergen acquired pharmacies of Walgreens Boots Alliance to strengthen retail Healthcare Distribution Market Trends.
The global healthcare distribution market provides significant opportunities such as entry of biosimilars and generic drugs, growing clinical trial material distribution, expansion of cold chain logistics and investment in digitization of supply chain processes. Key players are expanding globally through greenfield projects and associations with local players in high growth emerging markets of Asia Pacific, Middle East, Africa and Latin America. This will enable access to large untapped customer base in these regions.
Market Drivers
Growing prevalence of chronic diseases globally is a key driver for the healthcare distribution market. According to WHO, chronic diseases accounted for 71% of global deaths in 2019. Rising disease burden has increased demand for medicines, medical devices and hospital supplies which is fostering growth of healthcare distributors. Increased adoption of cold chain logistics for temperature sensitive products such as vaccines and biologics by distributors ensure last mile product quality and efficacy which is another market driver.
Market Restraints
Consolidation of pharmaceutical supply chain resulting in fewer distribution centers and emphasis on just-in-time inventory model can restrain market growth. Challenges in maintaining complete temperature control during transportation of cold chain products also act as a market barrier. Strict regulations for drug licensing, import and transport of narcotics require high compliance cost which restraint market especially in emerging regions.
Segment Analysis
The healthcare distribution market is dominating by pharmaceutical product distribution, which accounts for around 40% market share. Pharmaceutical product distribution comprises distribution of prescription and OTC drugs to pharmacies, hospitals, and doctors. This segment is dominating as demand for prescription and OTC drugs are high owing to rising prevalence of chronic diseases.
The medical device distribution is the second largest segment in healthcare distribution market. This segment deals in distribution of medical devices such as diagnostic imaging equipment, dental equipment, endoscopy equipment and many others to healthcare facilities such as hospitals, diagnostic centres and clinics. Growing healthcare infrastructure especially in developing countries is boosting the growth of this segment.
Global Analysis
North America is the fastest growing region in the global healthcare distribution market. This is attributed to factors such as high healthcare spending, presence of major market players and well-established healthcare infrastructure in the US and Canada. According to statistics, the US healthcare spending accounts for around 18% of its GDP.
Asia Pacific is expected to showcase highest growth rate during the forecast period in healthcare distribution market. Developing healthcare infrastructure, growing medical tourism, rising disposable incomes are some factors driving the growth of this regional market. Additionally, countries like China and India are witnessing increased FDIs in the healthcare sector which is positively impacting the distribution of pharmaceuticals and medical devices.
Gets More Insights on, Healthcare Distribution Market
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
0 notes
Becoming a Medical Supply Distributor:
If you are an ambitious entrepreneur reading this blog and looking for profitable medical distributor opportunities, then hurry and connect with a notable medical equipment and supplies manufacturing company!
0 notes
Blockchain Technology in a Nutshell
Blockchain technology is a revolutionary system that underpins cryptocurrencies like Bitcoin. It offers a decentralized, secure, and transparent way to record and transfer data, which has applications beyond digital currencies.
What is Blockchain Technology?
Blockchain is a distributed ledger technology that records transactions across multiple computers. These records are grouped into blocks,…
View On WordPress
0 notes
PL Global is doing more than just distributing pharmaceuticals; they are also bridging the gap in access to healthcare. Their pharmaceutical distribution experience optimizes the supply chain, ensuring that important pharmaceuticals are moved efficiently. By focusing on cold chain logistics, PL Global protects medicine integrity and extends healthcare availability worldwide.
Read more. https://plglobal.com/pharmaceutical-sector/
0 notes
Pharmapk is a renowned player in pharmaceutical distribution, medicine export, and contract manufacturing. Established in Lahore, Pakistan in 1990, we are committed to providing affordable generic medicines globally. Our involvement in international tenders, catering to hospitals and Ministries of Health worldwide, ensures widespread access to essential medications.
With exclusive distributorships of local manufacturers and multinational corporations, Pharmapk facilitates seamless import and export of medicines. Whether you seek generic medicines or pharmaceutical products from local or multinational sources in Pakistan, Pharmapk has you covered. Our partnerships enable us to offer quality products at reduced costs, prioritizing both affordability and quality.
In an age where online medicine purchases can be risky, Pharmapk ensures authenticity and safety. We guarantee genuine medications directly from reputable manufacturers, promoting confidence in every purchase. Specializing in international drug procurement for hospitals and government agencies, we contribute to global healthcare accessibility. Through collaboration with top Pakistani drug manufacturers, Pharmapk strives to make high-quality, affordable medicines accessible worldwide.
Pharmapk: Your Trusted Partner in Pharmaceutical Solutions
0 notes